Primary Cells Market is expected to register a CAGR of 8.13% to reach USD 1,233.67 Million till 2025.
Primary human cells are isolated directly from normal human tissue or blood cells via the enzymatic or mechanical method. Primary cells retain their fundamental cellular functions. Hence, their use in cell-based research programs is increasing significantly.
Key factors that drive the primary cells market are the rapid growth in the biotechnology and biopharmaceutical industries, growing cancer research, rising adoption of primary cells over cell lines, increasing demand for monoclonal antibodies, and increasing healthcare expenditure are anticipated to drive the growth of the market during the forecast period.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6296
However, factors such as the high cost of advanced primary cells, and the risk of contamination may hamper the growth of the market. The increasing preference of primary cells in research and development to develop new drug acts as opportunities for the growth of the primary cells market.
Market Dynamics
Growing cancer research across the world demand. Cancer is one of the major causes of death across the globe and is responsible for a large number of deaths. Different pharmaceutical companies and research institutes are involved in developing cancer treatment drugs using cell culture. The increasing prevalence of cancer across the globe is promoting the demand for research activities to develop new drugs. According to the National Cancer Institute in 2018, around 1,735,350 cases of cancer were diagnosed in the US alone.
Additionally, Cancer Research UK reported that in 2018 the new cases of cancer were reported to be 17 million across the world. The increasing number of populations suffering from cancer increases the demand for new research activities to develop new drugs, which ultimately increases the demand for products such as primary cell culture. For instance, the National Cancer Institute conducts different research on cancer biology, cancer genomics, and causes of cancer using primary cell culture. Additionally, there are different major and small manufacturers and suppliers, such as Merck KGaA and PromoCell GmbH, who provide primary cells for cancer research.
Segmentation
The Global Primary Cells Market is segmented into source, Type, and End User. By source, the market has been segmented into hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, and skeletal and muscle cells.
Based on type, the market has been segmented into human primary cells and animal primary cells. On the basis of end user, the market has been segmented into pharmaceutical and biotechnology companies and research institutes.
Regional Analysis
The Global Primary Cells Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is expected to hold the largest share of the global primary cells market. The market growth in this region is attributed to the presence of a well-established healthcare system, increasing prevalence of cancer, growing government funding in research, and technological advancements. According to the National Cancer Institute, around 1,685,210 new cases of cancer were diagnosed in the US in 2016. A huge patient pool with cancer is thus driving the growth of the market. Increasing healthcare expenditure by government organizations to provide a better life to the people drives the market growth. For instance, in 2017, the healthcare expenditure in the US was USD 3.5 trillion, and this expenditure increased to USD 3.65 Trillion in 2018.
Europe is expected to account for the second-largest market share during the forecast period. The European market is segmented into Germany, the UK, Italy, Spain, France, and the rest of Europe. Europe held a healthy share in the global primary cells market and is the second-largest market leader after the Americas, owing to the presence of favorable government initiatives & laws, rising prevalence of lifestyle-associated conditions, and the presence of developed economies such as Germany, the UK, and France. According to the Office for National Statistics, the gross domestic expenditure on research and development (R&D) activities was EUR 33.1 billion (USD 35.2 billion) in 2016. The increased spending on research and development activity boosts the market growth in this region.
Asia-Pacific is projected to exhibit the fastest market growth from 2019 to 2025 owing to the increasing per capita health spending, growing geriatric population base, and developing the healthcare sector in China, Japan, India, and Australia. According to the World Bank, the healthcare expenditure in India for the year 2016 was 3.66.% of the total GDP (gross domestic product).
The market in the Middle East and Africa is expected to hold the least market share owing to limited access to treatment facilities. However, the increasing invests by healthcare companies in countries such as Saudi Arabia and the launch of new products will help to strengthen the market growth.
Key Players
The Prominent Players in the Global Primary Cells Market are AllCells (US), American Type Culture Collection (ATCC) ( Virginia), Axol Bioscience Ltd (UK), Cell Biologics, Inc. (Chicago), Lonza Group, AG (Switzerland), Merck KGaA (Germany), PromoCell (UK), STEMCELL Technologies Inc. (Canada), ZenBio, Inc. (Research Triangle Park, NC), Thermo Fisher Scientific Inc. (US), and among others.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/primary-cells-market-6296
No comments:
Post a Comment